|Salary:||£33,184 to £34,976 UCL Grade 6, per annum|
|Placed On:||23rd September 2022|
|Closes:||6th October 2022|
Interview Date: TBC
Full time, Fixed Term: Post is available until 5 January 2023 in the first instance.
The main purpose of the post holder is to investigate the role of specific gene pathways in the pathogenesis of DMG-H3K27 and DMG-H3G34. It is expected the candidate will have a track record in carrying research in these paediatric tumours, in particular performing biochemical and cell biology experiments on cancer cell lines of these childhood tumours. The post holder will work under Dr Martinez-Barbera’s and Dr’ David Michod’s supervision.
Post is available until 5 January 2023 in the first instance.
The post holder will have University degree (BSc/MSc/MRes) in relevant area, e.g. stem cell biology/ cell biology / developmental biology/ cancer biology, experience of conducting research in DMG-H3K27 and DMG-H3G34 childhood tumours, published research papers, ability to supervise academic work by undergraduates, masters and doctorate students and proven research aptitude and laboratory experience, e.g. PCR genotyping, Real Time PCR, Immunoshistochemistry, Tissue culture, Histology applied to paediatric DMGs.
At GOS ICH we aim to always have a balanced interview panel that is representative of gender and ethnic diversity.
Applicants should apply online. To access further details about the position and how to apply please click on the ‘Apply’ button above.
If you have any queries regarding the application process, please contact ICH HR Team on email@example.com quoting job reference.
For informal enquiries related to post contact - firstname.lastname@example.org
Latest time for the submission of applications: 23:59.
UCL Taking Action for Equality
Our department holds an Athena SWAN Gold award, in recognition of our long-term commitment and 'beacon' status in advancing gender equality.
Type / Role: